15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress

Antioxidants and Redox Signaling

Volumn 10, Issue 12, 2008, Pages 2035-2046

  Jozkowicz, Alicja ^a   Was, Halina ^a   Taha, Hevidar ^a   Kotlinowski, Jerzy ^a   Mleczko, Katarzyna ^a   Cisowski, Jaroslaw ^a   Weigel, Guenter ^b   Dulak, Jozef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN J2; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; ACETYLCYSTEINE; DRUG DERIVATIVE; ETACRYNIC ACID; FORSKOLIN; HEMIN; HYDANTOIN DERIVATIVE; N ETHYLMALEIMIDE; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; PROSTANOID D RECEPTOR 1, HUMAN; PROTEIN KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS; UPREGULATION; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY;

ACETYLCYSTEINE; CELLS, CULTURED; CYCLIC AMP; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHACRYNIC ACID; ETHYLMALEIMIDE; FORSKOLIN; GENE EXPRESSION; HEMIN; HUMANS; HYDANTOINS; INTERLEUKIN-8; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDIN D2; PROTEIN KINASE INHIBITORS; REACTIVE OXYGEN SPECIES; RECEPTORS, PROSTAGLANDIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRANSFECTION; XANTHONES;

EID: 52949091128     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2032     Document Type: Article

References (60)

1. Abdollahi T, Robertson NM, Abdollahi A, and Litwack G. Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells. Apoptosis 10: 1383-1393, 2005.
2. 2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. Biochemistry 46: 2707-2718, 2007.
3. Arnold R and König W. Peroxisome-proliferator-activated receptor-γ agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells. Virology 346: 427-439, 2006.
4. 2 and the ligation of PPARγ. J Clin Invest 112: 945-955, 2003.
5. 2 in the regulation of microglial functions. Eur J Neurosci 12: 2215-2223, 2000.
6. 2 are associated with good outcome in acute atherothrombotic ischemic stroke. Stroke 36: 1189-1194, 2005.
7. Boisvert WA, Curtiss LK, and Terkeltaub RA. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 21: 129-137, 2000.
8. Breyer RM, Bagdassarian CK, Myers SA, and Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41: 661-669, 2001.
9. 2 increase mitochondrial complex I activity in endothelial cells. Am J Physiol Heart Circ Physiol 285: H2298-H2308, 2003.
10. Coleman RA, Smith WL, and Narumiya S. VIII International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994.
11. 2 on cell proliferation and apoptosis in ECV304 endothelial cells. Acta Pharmacol Sin 25: 47-53, 2004.
12. 2 in the developing choroid. Am J Heart Circ Physiol 278: H60-H66, 2000.
13. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, and Young LS. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 274: 16085-16096, 1999.
14. Eun CS, Han DS, Lee SH, Paik CH, Chung YW, Lee J, and Hahm JS. Attenuation of colonic inflammation by PPARγ in intestinal epithelial cells: effect on Toll-like receptor pathway. Dig Dis Sci 51: 693-697, 2006.
15. 2) in human THP-1 macrophages. Atherosclerosis 160: 11-20, 2002.
16. 2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. BMC Pharmacol 4: 6-16, 2004.
17. Grattagliano I, Caraceni P, Portincasa P, Domenicali M, Palmieri VO, Trevisani F, Bernardi M, and Palasciano G. Adaptation of subcellular glutathione detoxification system to stress conditions in choline-deficient diet induced rat fatty liver. Cell Biol Toxicol 19: 355-366, 2003.
18. Hashimoto K, Ethridge RT, and Evers BM. Peroxisome proliferator-activated receptor-γ ligand inhibits cell growth and invasion of human pancreatic cancer cells. Int J Gastrointest Cancer 32: 7-22, 2002.
19. Hayes JD, Flanagan JU, and Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 45: 51-88, 2005.
20. Hosoya T, Maruyama A, Kang MI, Kawatani Y, Shibata T, Uchida K, Warabi E, Noguchi N, Itoh K, and Yamamoto M. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J Biol Chem 280: 27244-27250, 2005.
21. 2 inhibits the expression of granulocyte-macrophage colony-stimulating factor in endothelial cells stimulated with lipopolysaccharide. Prostaglandins Other Lipid Mediat 71: 293-297, 2003.
22. Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, Hexham JM, Orth AP, Miraglia L, Meltzer J, Garza D, Chirn GW, McWhinnie E, Cohen D, Skelton J, Terry R, Yu Y, Bodian D, Buxton FP, Zhu J, Song C, and Labow MA. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci U S A 100: 12147-12152, 2003.
23. 2 induces synthesis of interleukin-8 by endothelial cells in a PPARγ-independent manner. Prostaglandins Other Lipid Mediat 66: 165-177, 2001.
24. Jozkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, and Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide, inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 5: 155-162, 2003.
25. 2 on VEGF synthesis depends on the induction of heme oxygenase-1. Antioxid Redox Signal 4: 577-585, 2002.
26. 2 inhibits expression of eNOS in human endothelial cells. Prostaglandin Other Lipid Mediat 74: 26-30, 2004.
27. 2 upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-γ. Acta Biochim Pol 50: 677-689, 2003.
28. 2 on the NF-κB pathway in human endothelial cells. Shock 2007, 28:722-726.
29. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 106: 189-197, 2000.
30. 2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells. Ann N Y Acad Sci 1090: 375-384, 2006.
31. Kondo M, Oya-Ito T, Kumagai T, Osawa T, and Uchida K. Cyclopentanone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem 276: 12076-12083, 2001.
32. Lee H, Schi W, Tontonoz P, Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, Hama S, Borromeo C, Evans RM, Berliner JA, and Nagy L. Role for peroxisome proliferator-activated receptor-α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and IL-8 by endothelial cells. Circ Res 87: 516-521, 2000.
33. 2. J Biol Chem 278: 19325-19330, 2003.
34. Li L, Julien B, Grenard P, Teixeira-Clerc F, Mallat A, and Lotersztajn S. Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts. J Hepatol 41: 407-413, 2004.
35. 2 stimulates HO-1 expression through p38 MAP kinase and Nrf2 pathway in rat vascular smooth muscle cells. Toxicol Appl Pharmacol 223: 20-27, 2007.
36. 2 protects brain from ischemia-reperfusion injury. Atheroscler Thromb Vasc Med 26: 481-487, 2006.
37. Ma P, Cui X, Wang S, Zhang J, Nishanian EV, Wang W, Wesley RA, and Danner RL. Nitric oxide post-transcriptionally up-regulates LPS-induced IL-8 expression through p38 MAPK activation. J Leukoc Biol 76: 278-187, 2004.
38. 2 enhances allyl alcohol-induced toxicity in rat hepatocytes. Toxicol Sci 77: 290-298, 2004.
39. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 2: 2557-2568, 1988.
40. Narumiya S, Sugimoto Y, and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
41. Pae HO, Oh GS, Choi BM, Kim YM, and Chung HT. A molecular cascade showing nitric oxide-heme oxygenase-1-vascular endothelial growth factor-interleukin-8 sequence in human endothelial cells. Endocrinology 146: 2229-2238, 2005.
42. Pasceri V, Wu HD, Willerson JT, and Yeh ETH. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators. Circulation 101: 235-238, 2000.
43. Sakurai T, Kojima C, Ochiai M, Ohta T, Sakurai MH, Waalkes MP, and Fujiwara K. Cellular glutathione prevents cytolethality of monomethylarsonic acid. Toxicol Appl Pharmacol 195: 129-141, 2004.
44. Sánchez-Gómez FJ, Gayarre J, Avellano MI, Pérez-Sala D. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. Arch Biochem Biophys 457: 150-159, 2007.
45. 2 family and the cardiovascular system. Curr Vasc Pharmacol 2: 103-114, 2004.
46. 2: the anti-inflammatory prostaglandin? Clin Immunol 114: 100-109, 2005.
47. 2 for induction of human articular chondrocyte apoptosis in arthritis. J Biol Chem 279: 37939-37950, 2004.
48. 2 metabolite generated during inflammatory processes. J Biol Chem 277: 10459-10466, 2002.
49. Shibata T, Yamada T, Ishii T, Kumazawa S, Nakamura H, Masutani H, Yodoi J, and Uchida K. Thioredoxin as a molecular target of cyclopentenone prostaglandins. J Biol Chem 28: 26046-26054, 2003.
50. Shu H, Wong B, Zhou G, Li Y, Berger J, Woods JW, Wright SD, and Cai TQ. Activation of PPARα or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human endothelial monocytic THP-1 cells. Biochem Biophys Res Commun 267: 345-349, 2000.
51. Srinivasan S, Bolick DT, Hatley ME, Natarajan R, Reilly KB, Yeh M, Chrestensen C, Sturgill TW, and Hedrick CC. Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes. J Biol Chem 279: 31930-31936, 2004.
52. 2 synthase expression in vascular endothelial cells. Circ Res 86: 967-973, 2000.
53. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, and Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 85: 1801-1813, 2004.
54. Torres M and Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors 17: 287-296, 2003.
55. 2 formation and characterization of its synthetases in various tissues of adult rats. Arch Biochem Biophys 260: 521-529, 1988.
56. Verrier E, Wang L, Wadham C, Albanese N, Hahn C, Gamble JR, Chatterjee KK, Vadas MA, and Xia P. PPARγ agonist ameliorate endothelial cell activation via inhibition of diacylglycerol protein kinase C signaling pathway. Circ Res 94: 1515-1522, 2004.
57. 2 in macrophages. Biol J Chem 282: 17964-17973, 2007.
58. Yano M, Matsumura T, Senokuchi T, Ishii N, Murata Y, Taketa K, Motoshima H, Taguchi T, Sonoda K, Kukidome D, Takuwa Y, Kawada T, Brownlee M, Nishikawa T, and Araki E. Statins activate peroxisome proliferator-activated receptor-γ through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 100: 1442-1451, 2007.
59. Zeineh K, Kawano Y, Fukuda J, Nasu K, Narahara H, and Miyakawa I. Possible modulators of IL-8 and GRO-α production by granulosa cells. Am J Reprod Immunol 50: 98-103, 2003.
60. 2. J Immunol 166: 7104-7111, 2001.